Safety and Efficacy of BroadBand Intense Pulsed Light Therapy for Dry Eye Disease with Meibomian Gland Dysfunction

References

• Shimazaki J. Definition and diagnostic criteria of dry eye disease: historical overview and future directions. Invest Ophthalmol Vis Sci. 2018;59(14):DES7–DES12. doi:10.1167/iovs.17-23475
   PubMed Web of Science ®Google Scholar
• Gupta PK, Vora GK, Matossian C, Kim M, Stinnett S. Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease. Can J Ophthalmol. 2016;51(4):249–253. doi:10.1016/j.jcjo.2016.01.005
   PubMed Web of Science ®Google Scholar
• Stapleton F, Alves M, Bunya VY, et al. Tfos dews ii epidemiology report. Ocul Surf. 2017;15(3):334–365.
   PubMed Web of Science ®Google Scholar
• Nichols KK. The international workshop on meibomian gland dysfunction: introduction. Invest Ophthalmol Vis Sci. 2011;52(4):1917–1921. doi:10.1167/iovs.10-6997
   PubMed Web of Science ®Google Scholar
• Qiao J, Yan X. Emerging treatment options for meibomian gland dysfunction. Clin Ophthalmol. 2013;7:1797.
   PubMedGoogle Scholar
• Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31(5):472–478. doi:10.1097/ICO.0b013e318225415a
   PubMed Web of Science ®Google Scholar
• Kashkouli MB, Fazel AJ, Kiavash V, Nojomi M, Ghiasian L. Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial. Br J Ophthalmol. 2015;99(2):199–204. doi:10.1136/bjophthalmol-2014-305410
   PubMed Web of Science ®Google Scholar
• Raulin C, Weiss RA, Schönermark MP. Treatment of essential telangiectasias with an intense pulsed light source (PhotoDerm VL). Dermatol Surg. 1997;23(10):941–945. doi:10.1111/j.1524-4725.1997.tb00755.x
   Web of Science ®Google Scholar
• McGill DJ, MacLaren W, Mackay IR. A direct comparison of pulsed dye, alexandrite, KTP and Nd: YAG lasers and IPL in patients with previously treated capillary malformations. Lasers Surg Med. 2008;40(6):390–398. doi:10.1002/lsm.20638
   PubMed Web of Science ®Google Scholar
• Park JM, Tsao H, Tsao S. Combined use of intense pulsed light and Q‐switched ruby laser for complex dyspigmentation among Asian patients. Lasers Surg Med. 2008;40(2):128–133. doi:10.1002/lsm.20603
   Web of Science ®Google Scholar
• Neuhaus IM, Zane LT, Tope WD. Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea. Dermatol Surg. 2009;35(6):920–928. doi:10.1111/j.1524-4725.2009.01156.x
   PubMed Web of Science ®Google Scholar
• Mariwalla K, Rohrer TE. Use of lasers and light‐based therapies for treatment of acne vulgaris. Lasers Surg Med. 2005;37(5):333–342. doi:10.1002/lsm.20276
   PubMed Web of Science ®Google Scholar
• Piccolo D, Di Marcantonio D, Crisman G, et al. Unconventional use of intense pulsed light. Biomed Res Int. 2014;2014(10):1–10. doi:10.1155/2014/618206
   Web of Science ®Google Scholar
• Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg. 2015;33(1):41–46. doi:10.1089/pho.2014.3819
   PubMed Web of Science ®Google Scholar
• Jiang X, Lv H, Song H, et al. Evaluation of the safety and effectiveness of intense pulsed light in the treatment of meibomian gland dysfunction. J Ophthalmol. 2016;2016(1):1–8.
   Google Scholar
• Craig JP, Chen YH, Turnbull PR. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2015;56(3):1965–1970. doi:10.1167/iovs.14-15764
   PubMed Web of Science ®Google Scholar
• Liu R, Rong B, Tu P, et al. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017;183:81–90. doi:10.1016/j.ajo.2017.08.021
   PubMed Web of Science ®Google Scholar
• Xue AL, Wang MT, Ormonde SE, Craig JP. Randomised double-masked placebo-controlled trial of the cumulative treatment efficacy profile of intense pulsed light therapy for meibomian gland dysfunction. Ocul Surf. 2020;18(2):286–297. doi:10.1016/j.jtos.2020.01.003
   PubMed Web of Science ®Google Scholar
• Ocak SY, Karakus S, Ocak OB, et al. Intense pulse light therapy treatment for refractory dry eye disease due to meibomian gland dysfunction. Int Ophthalmol. 2020;40(5):1–7.
   Web of Science ®Google Scholar
• Choi M, Han SJ, Ji YW, et al. Meibum expressibility improvement as a therapeutic target of intense pulsed light treatment in meibomian gland dysfunction and its association with tear inflammatory cytokines. Sci Rep. 2019;9(1):1–8.
   PubMed Web of Science ®Google Scholar
• Piyacomn Y, Kasetsuwan N, Reinprayoon U, Satitpitakul V, Tesapirat L. Efficacy and safety of intense pulsed light in patients with meibomian gland dysfunction—a randomized, double-masked, sham-controlled clinical trial. Cornea. 2020;39(3):325–332. doi:10.1097/ICO.0000000000002204
   PubMed Web of Science ®Google Scholar
• Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf. 2019;17(1):104–110. doi:10.1016/j.jtos.2018.11.004
   PubMed Web of Science ®Google Scholar
• Zhang-Nunes S, Guo S, Lee D, Chang J, Nguyen A. Safety and efficacy of an augmented intense pulse light protocol for dry eye syndrome and blepharitis. Photobiomodul Photomed Laser Surg. 2020;39(3):178–184.
   Web of Science ®Google Scholar
• Bitter P. Intense pulsed light: where we are now? Dermatol Rev. 2021;2(2):60–68. doi:10.1002/der2.63
   Google Scholar
• Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):2006–2049. doi:10.1167/iovs.10-6997f
   PubMed Web of Science ®Google Scholar
• Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124(6):869–871. doi:10.1001/archderm.1988.01670060015008
   PubMedGoogle Scholar
• Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615–621. doi:10.1001/archopht.118.5.615
   PubMedGoogle Scholar
• Jackson WB. Management of dysfunctional tear syndrome: a Canadian consensus. Can J Ophthalmol. 2009;44(4):385–394. doi:10.3129/i09-015
   PubMed Web of Science ®Google Scholar
• Hong J, Sun X, Wei A, et al. Assessment of tear film stability in dry eye with a newly developed keratograph. Cornea. 2013;32(5):716–721. doi:10.1097/ICO.0b013e3182714425
   PubMed Web of Science ®Google Scholar
• Alfaro-Juárez A, Caro-Magdaleno M, Montero-Iruzubieta J, et al. Keratograph 5M as a useful and objective tool for evaluating the ocular surface in limbal stem cell deficiency. Clin Ophthalmol. 2019;13:2025. doi:10.2147/OPTH.S218313
   PubMed Web of Science ®Google Scholar
• Yokoi N, Komuro A. Non-invasive methods of assessing the tear film. Exp Eye Res. 2004;78(3):399–407. doi:10.1016/j.exer.2003.09.020
   PubMed Web of Science ®Google Scholar
• Wu S, Hong J, Tian L, Cui X, Sun X, Xu J. Assessment of bulbar redness with a newly developed keratograph. Optom Vis Sci. 2015;92(8):892–899. doi:10.1097/OPX.0000000000000643
   PubMed Web of Science ®Google Scholar
• Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47(3):1236–1240. doi:10.1167/iovs.05-0981
   PubMed Web of Science ®Google Scholar
• Nichols JJ, Berntsen DA, Mitchell GL, Nichols KK. An assessment of grading scales for meibography images. Cornea. 2005;24(4):382–388. doi:10.1097/01.ico.0000148291.38076.59
   PubMed Web of Science ®Google Scholar
• Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23(8):762–770. doi:10.1097/01.ico.0000133997.07144.9e
   PubMed Web of Science ®Google Scholar
• De Godoy CHL, da Costa Silva PF, De Araujo DS, et al. Evaluation of effect of low-level laser therapy on adolescents with temporomandibular disorder: study protocol for a randomized controlled trial. Trials. 2013;14(1):1–6.
   Google Scholar
• Irvine J, Chong SL, Amirjani N, Chan KM. Double‐blind randomized controlled trial of low‐level laser therapy in carpal tunnel syndrome. Muscle Nerve. 2004;30(2):182–187. doi:10.1002/mus.20095
   Web of Science ®Google Scholar
• Mathers WD, Shields WJ, Sachdev MS, Petroll WM, Jester JV. Meibomian gland dysfunction in chronic blepharitis. Cornea. 1991;10(4):277–285. doi:10.1097/00003226-199107000-00001
   PubMed Web of Science ®Google Scholar
• Nagymihályi A, Dikstein S, Tiffany JM. The influence of eyelid temperature on the delivery of meibomian oil. Exp Eye Res. 2004;78(3):367–370. doi:10.1016/S0014-4835(03)00197-0
   Web of Science ®Google Scholar
• Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea. 2008;27(10):1142–1147. doi:10.1097/ICO.0b013e3181814cff
   PubMed Web of Science ®Google Scholar
• Stonecipher K, Abell TG, Chotiner B, Chotiner E, Potvin R. Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction. Clin Ophthalmol. 2019;13:993–999. doi:10.2147/OPTH.S213664
   PubMed Web of Science ®Google Scholar
• Stonecipher K, Komm C, Potvin R, et al. Low level light therapy as an adjunct treatment for meibomian gland dysfunction. Acta Sci Ophthalmol. 2020;3(11):13–18. doi:10.31080/ASOP.2020.03.0177
   Google Scholar